Personalised Asthma Action Plan
Download
Other Resources
Environmental Impact of Inhalers
Download
The content of this website has been developed by Mundipharma Limited for healthcare professionals. Mundipharma is responsible for the content of this website and is also the copyright owner/authorised user of the content.
Please select an option to continue
I confirm I am a UK Healthcare professional
Reporting adverse events
Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.mhra.gov.uk/. Adverse events should also be reported to Napp Pharmaceuticals Limited at drugsafetyuk@napp.co.uk.
I am a patient or a member of the general public
Take me thereReporting adverse events
If you get any side-effects, talk to your doctor, nurse or pharmacist. This includes any possible side-effects not listed in the package leaflet. You can also report side-effects directly via the Yellow Card scheme at www.yellowcard.mhra.gov.uk/. By reporting side-effects you can help provide more information on the safety of this medicine.
Report An Adverse Event
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard
Adverse events should also be reported to Napp Pharmaceuticals Limited on 01223 424444 or drugsafetyuk@napp.co.uk
Report Adverse Event
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard
Adverse events should also be reported to Napp Pharmaceuticals Limited on 01223 424444 or drugsafetyuk@napp.co.uk
Copyright 2021 Napp Pharmaceuticals. All Rights Reserved. | JOB CODE: UK-ADI-2300001 | Prepared: August 2023
Your browser is not supported.
To view this content, please use one of the following browsers:
- Microsoft Edge
- Chrome
- Safari
This feature is not available in mobile. Use Tablet/Computer to access it.
Reporting adverse events
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Napp Pharmaceuticals Limited on 01223 424444 or drugsafetyUKandROI@mundipharma.com.